Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.

Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL

DOI: 10.1002/cam4.210
Published: 2014 Jun
Container: Cancer medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.210,
  title = {Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.},
  author = {Wong ET and Lok E and Swanson KD and Gautam S and Engelhard HH and Lieberman F and Taillibert S and Ram Z and Villano JL},
  year = {2014},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.210},
  url = {https://doi.org/10.1002/cam4.210}
}

RIS

TY  - JOUR
TI  - Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.
AU  - Wong ET
AU  - Lok E
AU  - Swanson KD
AU  - Gautam S
AU  - Engelhard HH
AU  - Lieberman F
AU  - Taillibert S
AU  - Ram Z
AU  - Villano JL
PY  - 2014
JO  - Cancer medicine
DO  - 10.1002/cam4.210
UR  - https://doi.org/10.1002/cam4.210
ER  -

APA

ET, W., E, L., KD, S., S, G., HH, E., F, L., S, T., Z, R., & JL, V. (2014). Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma.. Cancer medicine. https://doi.org/10.1002/cam4.210

Source records

pubmed · retrieved 2026-09-25T23:35:21.399Z
europe-pmc · retrieved 2026-09-25T23:35:21.406Z
hal · retrieved 2026-09-25T23:35:21.461Z